Francisco Leon

Francisco Leon is a prominent figure in the biotechnology sector, currently serving as Founder and CEO of Tolerance Bio, which aims to enhance healthspan through thymus function restoration. Simultaneously, Francisco is a Co-Founder at Paulex Bio, Avalor Therapeutics, and Praetorian Bio, focusing on diabetes therapies, precision medicine for chronic inflammation, and innovative oral health solutions, respectively. Francisco also holds significant positions as a Board Member at LAPIX Therapeutics and Founding Partner at VAXDYN SL, where the work involves developing vaccines for antibiotic-resistant bacteria. Previously, as Chief Scientific Officer at Provention Bio, Francis contributed to its acquisition by Sanofi and the advancement of critical therapeutic pipelines. Francisco holds a PhD in Mucosal Immunology, alongside clinical specialties in Immunology and a medical degree in Allergy and Immunology from prestigious institutions in Spain.